Press Releases
| Date ⇅ | Title ⇅ | Organisation ⇅ | Entities | Categories | Summary |
|---|---|---|---|---|---|
| 2025-11-08 | Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American ... | Regeneron announced positive Phase 2 results for two investigational factor XI antibodies, REGN7508Cat and REGN9933A2, in preventing venous thrombo... |
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
Regeneron announced positive Phase 2 results for two investigational factor XI antibodies, REGN7508Cat and REGN9933A2, in preventing venous thrombo...